Search Results

Filter
  • 1-10 of  52,750 results for ""Arsenic Trioxide""

Your Filters

Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Leucocytosis during all-trans retinoic acid and arsenic trioxide treatment in acute promyelocytic leukaemia.

  • Authors : Yanada M; Nagoya City University East Medical Center, Nagoya, Japan.

Subjects: Leukemia, Promyelocytic, Acute*/Leukemia, Promyelocytic, Acute*/Leukemia, Promyelocytic, Acute*/drug therapy ; Arsenic Trioxide*/Arsenic Trioxide*/Arsenic Trioxide*/therapeutic use ; Arsenic Trioxide*/Arsenic Trioxide*/Arsenic Trioxide*/adverse effects

  • Source: British journal of haematology [Br J Haematol] 2024 Nov; Vol. 205 (5), pp. 1672-1673. Date of Electronic Publication: 2024 Sep 15.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Protective Effect of Berberine Nanoparticles Against Cardiotoxic Effects of Arsenic Trioxide.

  • Authors : Hosseini SH; Geriatric Health Research Center, Birjand University of Medical Sciences, Birjand, Iran.; Nazarian M

Subjects: Arsenic Trioxide*/Arsenic Trioxide*/Arsenic Trioxide*/toxicity ; Berberine*/Berberine*/Berberine*/pharmacology ; Rats, Wistar*

  • Source: Cardiovascular toxicology [Cardiovasc Toxicol] 2024 Dec; Vol. 24 (12), pp. 1311-1316. Date of Electronic Publication: 2024 Sep 30.Publisher: Humana Press Country of Publication: United States NLM ID: 101135818 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Leucocytosis during induction therapy with all-trans-retinoic acid and arsenic trioxide in acute promyelocytic leukaemia predicts differentiation syndrome and treatment-related complications.

  • Authors : Cicconi L; Department of Hematology, SM Goretti Hospital, University Polo Pontino, Latina, Italy.; Bisegna M

Subjects: Leukemia, Promyelocytic, Acute*/Leukemia, Promyelocytic, Acute*/Leukemia, Promyelocytic, Acute*/drug therapy ; Arsenic Trioxide*/Arsenic Trioxide*/Arsenic Trioxide*/adverse effects ; Arsenic Trioxide*/Arsenic Trioxide*/Arsenic Trioxide*/therapeutic use

  • Source: British journal of haematology [Br J Haematol] 2024 Nov; Vol. 205 (5), pp. 1727-1733. Date of Electronic Publication: 2024 Sep 14.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Arsenic trioxide and p97 inhibitor synergize against acute myeloid leukemia by targeting nascent polypeptides and activating the ZAKα-JNK pathway.

  • Authors : Xie S; Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine and School of Life Sciences and Biotechnology, Shanghai, China. .; Liu H

Subjects: Arsenic Trioxide*/Arsenic Trioxide*/Arsenic Trioxide*/pharmacology ; Arsenic Trioxide*/Arsenic Trioxide*/Arsenic Trioxide*/therapeutic use ; Leukemia, Myeloid, Acute*/Leukemia, Myeloid, Acute*/Leukemia, Myeloid, Acute*/drug therapy

  • Source: Cancer gene therapy [Cancer Gene Ther] 2024 Oct; Vol. 31 (10), pp. 1486-1497. Date of Electronic Publication: 2024 Aug 09.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 9432230 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Early predictor for differentiation syndrome in newly diagnosed acute promyelocytic leukaemia patients treated with single-agent arsenic trioxide.

  • Authors : Gao Y; The First Affiliated Hospital of Harbin Medical University, Long Jiang Road, Harbin, 150007, Heilongjiang Province, China.; Xi Y

Subjects: Leukemia, Promyelocytic, Acute*/Leukemia, Promyelocytic, Acute*/Leukemia, Promyelocytic, Acute*/drug therapy ; Leukemia, Promyelocytic, Acute*/Leukemia, Promyelocytic, Acute*/Leukemia, Promyelocytic, Acute*/diagnosis ; Leukemia, Promyelocytic, Acute*/Leukemia, Promyelocytic, Acute*/Leukemia, Promyelocytic, Acute*/blood

  • Source: Annals of hematology [Ann Hematol] 2024 Oct; Vol. 103 (10), pp. 3947-3954. Date of Electronic Publication: 2024 Apr 29.Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9107334 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Distinctive features associated with differentiation syndrome in acute promyelocytic leukemia in patients treated by all-trans retinoic acid and arsenic trioxide.

  • Authors : Cingelova S; National Cancer Institute, Bratislava, Slovakia, Oncohematology Department, Slovakia. Electronic address: .; Mikuskova E

Subjects: Leukemia, Promyelocytic, Acute*/Leukemia, Promyelocytic, Acute*/Leukemia, Promyelocytic, Acute*/drug therapy ; Arsenic Trioxide*/Arsenic Trioxide*/Arsenic Trioxide*/adverse effects ; Arsenic Trioxide*/Arsenic Trioxide*/Arsenic Trioxide*/therapeutic use

  • Source: Leukemia research [Leuk Res] 2024 Oct; Vol. 145, pp. 107567. Date of Electronic Publication: 2024 Aug 22.Publisher: Pergamon Press Country of Publication: England NLM ID: 7706787 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Chemotherapy-free approaches to newly-diagnosed acute promyelocytic leukaemia: is oral-arsenic trioxide/all-trans retinoic acid/ascorbic acid the answer?

  • Authors : Gill H; Department of Medicine, School of Clinical Medicine, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong, China.

Subjects: Leukemia, Promyelocytic, Acute*/Leukemia, Promyelocytic, Acute*/Leukemia, Promyelocytic, Acute*/drug therapy ; Leukemia, Promyelocytic, Acute*/Leukemia, Promyelocytic, Acute*/Leukemia, Promyelocytic, Acute*/diagnosis ; Tretinoin*/Tretinoin*/Tretinoin*/therapeutic use

  • Source: Expert review of hematology [Expert Rev Hematol] 2024 Oct; Vol. 17 (10), pp. 661-667. Date of Electronic Publication: 2024 Aug 12.Publisher: Taylor & Francis Country of Publication: England NLM ID: 101485942 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Low-dose arsenic trioxide inhibits pancreatic stellate cell activation via LOXL3 expression to enhance immunotherapy in pancreatic cancer.

  • Authors : Zhao Y; Department of Gastroenterology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China.; Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China.

Subjects: Arsenic Trioxide*/Arsenic Trioxide*/Arsenic Trioxide*/pharmacology ; Arsenic Trioxide*/Arsenic Trioxide*/Arsenic Trioxide*/administration & dosage ; Pancreatic Neoplasms*/Pancreatic Neoplasms*/Pancreatic Neoplasms*/drug therapy

  • Source: British journal of cancer [Br J Cancer] 2024 Dec; Vol. 131 (12), pp. 1928-1941. Date of Electronic Publication: 2024 Nov 05.Publisher: Nature Publishing Group on behalf of Cancer Research UK Country of Publication: England NLM ID: 0370635 Publication Model: Print-Electronic Cited

Record details

×
Academic Journal

Mitigating effect of gallic acid on zinc oxide nanoparticles and arsenic trioxide-induced spermatogenesis suppression, testicular injury, hormonal imbalance, and immunohistochemical changes in rats.

  • Authors : Behairy A; Department of Physiology, Faculty of Veterinary Medicine, Zagazig University, Zagazig, 44519, Egypt.; Hashem MMM

Subjects: Testis*/Testis*/Testis*/drug effects ; Testis*/Testis*/Testis*/metabolism ; Testis*/Testis*/Testis*/pathology

  • Source: Naunyn-Schmiedeberg's archives of pharmacology [Naunyn Schmiedebergs Arch Pharmacol] 2024 Dec; Vol. 397 (12), pp. 9859-9875. Date of Electronic Publication: 2024 Jun 27.Publisher: Springer Verlag Country of Publication: Germany NLM ID: 0326264 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Geomechanical aspects of stabilizing arsenic trioxide roaster waste in cemented paste backfill at the Giant Mine, Canada.

  • Authors : Mohammadi A; Research Institute on Mines and the Environment, Université du Québec en Abitibi-Témiscamingue (UQAT), Rouyn-Noranda, QC, Canada. Electronic address: .; Demers I

Subjects: Arsenic Trioxide*/Arsenic Trioxide*/Arsenic Trioxide*/chemistry ; Mining*; Canada

  • Source: Journal of environmental management [J Environ Manage] 2024 Nov; Vol. 370, pp. 123022. Date of Electronic Publication: 2024 Oct 22.Publisher: Academic Press Country of Publication: England NLM ID: 0401664 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
  • 1-10 of  52,750 results for ""Arsenic Trioxide""